Gland Pharma Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
4/10
|
38.2 | 59.63 | -35.93% | 41.79 | -8.58% |
| P/S |
|
5.23 | 9.32 | -43.89% |
|
|
| P/BV |
|
3.38 | 6.64 | -49.05% |
|
|
| P/FCF |
|
33.77 | -106.44 | -131.72% |
|
|
| Ev/Ebitda |
|
19.64 | 141.59 | -86.13% |
|
|
| Ev/S |
|
5.23 | 9.59 | -45.45% |
|
|
| Ev/FCF |
|
49.33 | -85.26 | -157.86% |
|
|
| E/P |
|
0.0382 | 0.0211 | 81.26% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
26.65 | 5.56 | 379.46% | 36.69 | -27.37% |
| ROE |
|
9.26 | 10.72 | -13.65% |
|
|
| ROA |
|
7.95 | 7.64 | 4.06% |
|
|
| ROIC |
|
0 | 15.91 | -100% |
|
|
| ROS |
|
13.69 | -4.5 | -404.16% |
|
|
| ROCE |
|
12.51 | 13.07 | -4.32% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.2476 | 121.74 | -99.8% | 0.1009 | +145.36% |
| Nеt Debt/Ebitda |
|
0.01 | 121.47 | -99.99% |
|
|
| Debt/Ratio |
|
0.0349 | 0.145 | -75.93% |
|
|
| Debt/Equity |
|
0.2215 | 1.97 | -88.73% |
|
|
| Debt/Net Income |
|
0.4818 | 5.06 | -90.49% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2.68/10
|
1.07 | 9.57 | -88.82% | 1.07 | +0.2216% |
| Number of years of dividend growth |
|
0 | 0.9146 | -100% | ||
| DSI |
|
1 | 0.8306 | 20.39% |
|
|
| Average dividend growth |
|
0 | -3.39 | -100% |
|
|
| Average percentage for 5 years |
|
1.07 | 14.83 | -92.8% |
|
|
| Average percentage for payments |
|
0 | 24.67 | -100% |
|
|
| Difference from average difference in sector |
|
-8.5 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
119.37 | 42.4 | 181.53% | ||
| Growth impulse Ebitda in 5 years |
|
39.46 | 26.84 | 47.02% | ||
| Growth impulse Net Income in 5 years |
|
-0.0515 | 77.79 | -100.07% | ||
| Growth impulse FCF in 5 years |
|
18.22 | -25.16 | -172.42% | ||
| Growth impulse EPS in 5 years |
|
-0.9315 | -13.77 | -93.24% |
IP Score
4.98/10
